DARU, Journal of Pharmaceutical Sciences
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q3 | 49.4% | 0.519 | Q3 | 62.2% |
| 2024 | 2.1 | Q3 | 37.4% | 0.642 | Q2 | 70.7% |
| 2023 | 2.5 | Q3 | 50.3% | 0.625 | Q2 | 72.2% |
| 2022 | 3.6 | Q2 | 66.3% | 0.641 | Q2 | 74.1% |
| 2021 | 4.1 | Q2 | 69.7% | 0.580 | Q2 | 71.8% |
| 2020 | — | — | 0.645 | Q2 | 73.9% | |
| 2019 | — | — | 0.532 | Q2 | 69.3% | |
| 2018 | — | — | 0.658 | Q2 | 73.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2008-2231
ISSN
1560-8115
region
Western Europe
coverage
2000-2026